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Introduction
Liposomes are artificially constructed nanostructures inspired by the composition and structure of cell membranes. Liposomes have been studied extensively in the past decades because of their superior properties over other nanosystems, such as non-toxicity, non-immunogenicity, and good biocompatibility and biodegradability. By 2014, fifteen lipid-based therapeutics have gained clinical approval, such as Doxil [1] , DaunoXome, etc., for the treatment of cancer, fungi, microbes, analgesia, etc., and more are undergoing clinical trials [2] . Different methods have been developed for producing liposomes, such as thin-film hydration, freeze-drying, detergent depletion and alcohol injection [3] . These conventional methods are all based on bulk synthesis, and require post-processing steps (extrusion or sonication) to homogenise the size. Multifunctional liposomes need more post-processing steps, such as postconjugation steps to add a targeting ligand and/or to conjugate imaging molecules, resulting in big batch-to-batch variations and poor control over their size and surface properties, which play key roles in determining their behaviour in vivo [4] . The difficulties in manufacturing multifunctional liposomes for targeted delivery limits their large-scale production, which is one of the reasons that no active targeted liposome has gained clinical approval, even though significant amount of work has been directed to make multifunctional liposomes. Therefore, it is of great significance to develop a robust platform technology for preparing multifunctional liposomes with reproducible and precisely controlled properties.
Microfluidic technology has emerged as an alternative to bulk methods for synthesising various materials in recent years [5] [6] [7] . The microfluidic hydrodynamic flow focusing (HFF) method has demonstrated its versatility in making various kinds of nanomaterials through selfassembly, including polymeric nanoparticles [8] , liposomes [9] and lipid-polymer hybrid nanoparticles [10] . This HFF method allows the formation of liposomes through a single-step self-assembly. Basically, a lipid-containing alcohol solution that is introduced from the central microchannel mixes with an aqueous buffer solution from the vertical channels. As the alcohol diffuses to the aqueous buffer, the lipid materials solubilised in the alcohol becomes less soluble and self-assembles into planar lipid bilayer discs. Subsequently, these lipid discs bend to reduce the exposure of the hydrophobic lipid chain to the hydrophilic buffer and finally close into spherical liposomes [11] . This single-step method offers better control over the properties of liposomes, such as particle size, size distribution and surface properties (PEGylation and targeting ligand) [11] [12] [13] [14] . More importantly, this method can be easily scaled up. Hood et al. recently reported the high throughput production of liposomes using a high aspect ratio HFF device. The production rate was as high as 95 mg h -1 , which was approximately 1000 times higher than using the original HFF device [15] . Furthermore, the production throughput can be increased through parallelization [16] . Therefore, microfluidic technology holds great potential in producing liposomes for practical applications. However, current work has been focusing on designing various microfluidic devices for making liposomes, while little effort has been made to synthesise multifunctional liposomes (PEGylated and targeted liposomes). To the best of our knowledge, none have investigated their biological functions, which are critical to assess whether the liposomes prepared in microfluidic devices have the correct conformation and thus biological function.
In this study, three liposome formulations, that is, plain liposomes, PEGylated liposomes, and an active targeting ligand -folic acid modified liposomes, were prepared using the single-step microfluidic hydrodynamic flow focusing method. Size, polydispersity and surface properties of the three liposome formulations as a function of flow rate ratios were investigated. Their biological functions were systemically studied in vitro using both the two-dimensional cell monolayer model and the three-dimensional tumour spheroid model. Other properties such as serum stability and phagocytosis were also investigated. 
Materials and methods

Materials
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-distearoyl-sn-glycero-3- phosphoethanolamine-N-[
Microfluidic device fabrication
The microfluidic device was fabricated using photolithography and soft lithography. The microchannel pattern was designed using the AutoCAD software and was printed to a chrome mask. For SU-8 master fabrication (photolithography), SU-8 was spin-coated to a clean 4-inch silicon wafer, followed by ultraviolet exposure using the patterned chrome mask as the template. After baking, developing and washing, the SU-8 master was ready to use. Soft lithography was conducted by pouring Polydimethylsiloxane (PDMS) over the SU-8 master mold, followed by incubation at 80 °C for 30 min. The cross-linked PDMS was peeled off from the SU-8 master mold, and then holes were punched at inlets and outlets. Finally, the PDMS layer was bonded to a glass slide coated with a thin layer of PDMS to form a microfluidic device. focusing device procedure was monitored using an inverted optical microscope (Nikon, Tokyo, Japan). The size, polydispersity index (PDI) and zeta-potential of the liposomes synthesised were determined using a Zetasizer Nano ZS (Malvern Instruments, Worcestershire, UK). The morphology of Plain-Lip, PEG-Lip and FA-Lip at FRR=12:1 were observed using a transmission electron microscopy (Jeol, Tokyo, Japan). Samples were dropped onto a copper TEM grid with a carbon film and air-dried at room temperature followed by negative-staining using 1% uranyl acetate. the excitation and emission wavelengths at 549 nm and 565 nm, respectively, using a flow cytometer.
Preparation and characterisation of liposomes
In vitro
3D tumour spheroid uptake
To establish the tumour spheroid model, SKOV3 or MCF-7 cells at a density of 5×10 3 cells/well were seeded into a 96 well plate which was pre-coated with 50 µL 2% low melting point agarose, then applied with centrifugation (1000g, 10 min) to initiate the formation of spheroids. They were monitored with an optical microscope and were ready to use after 7 days.
Then DiI labelled liposomes were incubated with spheroids for 24 h and followed by washing with PBS and fixation with 4% paraformaldehyde. At last, spheroids were subjected to a confocal microscope. For the quantitative analysis, after incubation with DiI labelled liposomes for 4 h, 10 spheroids for each group were gathered and treated with 200 µL Accumax solution for 30 min at 37 °C with pipetting every 10 min. After dissociation, cells were washed three times with PBS and then analysed using a flow cytometry.
Statistical analysis
Statistical analysis were performed by the one-way ANOVA for multiple groups, and p value <0.05, <0.01 and <0.001 was marked as *, ** and ***, respectively. nm show the longest blood half-lives [17] , best tumour accumulation [17, 18] and tumour retention [19] . The size homogeneity can also affect the biodistribution of liposomes.
Liposomes with a narrower size distribution showed a lower liver and spleen accumulation [20] . Neutralised liposomes and PEGylated liposomes also exhibited longer blood circulation time and better tumour accumulation [21] . Therefore, it is vital to prepare liposomes with uniform size and controlled surface properties.
The effects of the flow rate ratio of the IPA to the PBS phase (4:1, 8:1, 12:1 and 16:1) on particle size, particle size distribution index (PDI) and zeta-potential of the three formulations were systematically investigated. The size of the three liposomes all decreased with increasing the flow rate ratio. A non-equilibrium kinetic model can be used to explain the formation of the liposomes. This model proposes that two parameters, i.e., the growth time of the lipid discs and the rate of closing the discs into spherical vesicles, determine the liposome size [11] .
Higher FRRs result in a thinner alcohol stream thus a thinner diffusion layer, so that the growth time of the lipid discs becomes shorter. Also, as the alcohol concentration decreases rapidly at higher FRRs, the discs closes faster [22] . Therefore, higher FRRs produce smaller liposomes.
At a FRR of 12:1, the average sizes of Plain-Lip, PEG-Lip and FA-Lip were 108 ± 4 nm, 56 ± 1nm and 92 ± 3 nm, respectively. The PEGylated liposomes showed the smallest size compared to Plain-Lip and FA-lip, which is consistent with previous studies [23] . The addition of DSPE-PEG-FA led to a slight increase of the liposome size. Fig. 2B shows the PDI of the three liposomes indicating that this HFF method produced liposome particles with narrow size distribution with all PDIs below 0.2. For the Plain-Lip, the PDI decreased with the flow rate ratio, but for the other two formulations, no obvious trend was observed. At a FRR of 12:1, the PDI of plain, PEG and FA-Lip was 0.09 ± 0.01, 0.13 ± 0.01 and 0.14 ± 0.02, respectively.
As expected, the Plain-Lip exhibited a negative charge at approximately -10 mV due to the presence of negatively charged DCP, which was increased to about zero by simple PEGylation because of the charge screening effect of the PEG2000. The FA-lip showed similar zeta potential as that of the PEG-Lip, indicating that the addition of DSPE-PEG2000-Folate didn't change the surface charge. At a FRR of 12:1, the zeta-potential of Plain-Lip, PEG-Lip and FA-Lip was -9.5 ± 0.9 mV, -0.8 ± 0.4 mV and -0.9 ± 0.1 mV, respectively. The morphology of all the liposomes was observed using TEM, showing crumped and deformed shapes due to the vacuum conditions under TEM. The sizes of PEG-Lip and FA-Lip were smaller than that of the Plain-Lip (Fig. 2D) , which is in consistence with the DLS measurement. The lipid bilayer structure could be observed clearly.
In this study, liposomes synthesised at the FRR of 12:1 were selected for the following in vitro experiments, including serum stability, macrophage uptake, two-dimensional cell monolayer and three-dimensional tumour spheroids uptake. To label the liposomes, DiI (10 µg/mL) was 
Serum stability
Liposome stability against physiological condition is a vital prerequisite for its in vivo use. To study their serum stability, liposomes were incubated with 50 % FBS to mimic the interactions with the serum in vivo. Two important parameters, turbidity and particle size, were monitored for 24 h. The relative turbidity for the three liposome formulations remained stable at approximately 1.0 (Fig. 3A) . Additionally, the mean diameter of these liposomes didn't change much over the 24 h period of time (Fig. 3B) . These results demonstrated the good stability of these three liposome formulations in physiological mimicking conditions. Two major factors contribute to the good stability of the three liposome formulations. Firstly, the surface property of nanoparticles plays key roles in determining their serum stability. As serum proteins are negatively charged, they are prone to interact with positively charged nanoparticles thus leading to aggregation through electrostatic interactions. So the negatively charged Plain-lip showed good stability because of the repulsion between the liposomes and serum proteins [24] .
Secondly, PEGylation can also increase serum stability by excluding the serum protein binding and adhesion through steric repulsion. Therefore, even though the PEG-lip and FA-lip had very low surface charge, they were still able to remain stable in the serum [25] .
Cellular uptake of liposomes by RAW 264.7 macrophage cells
Macrophage is a type of white blood cells involved in the innate immunity that recognises and destructs cell debris and foreign substances, such as pathogens and particles. It has been widely accepted that high macrophage uptake correlates with short circulation time. To achieve long circulation, the macrophage uptake needs to be minimised. PEGylation is a widely used method to evade the immune system and thus prolong the circulation time. Fig. 4 shows the RAW 264.7 cell uptake of the three liposome formulations. Compared to Plain-Lip, PEG-Lip and FA-Lip had significantly decreased cell uptake, which is consistent with previously reported results [26, 27] . This reduced phagocytosis of the PEG-Lip and FA-Lip is essential for a longer circulation time in vivo, which favours their accumulation in tumour sites. Furthermore, it has been noted that PEG-Lip and FA-Lip had different particle size (55 nm and 90 nm, respectively), but they possessed similar phagocytosis efficiency. It has been shown in some studies that particles with larger size have higher macrophage uptake [28] . However in our case the particle size didn't have any effect on the uptake probably because the sizes of PEG-Lip and FA-lip are both smaller enough to avoid phagocytosis.
Folate receptor expression
Folate receptor was first discovered as a tumour marker on a human ovarian carcinoma cell line in 1991 [29] , and then approximately 90% of ovarian carcinomas as well as other cancer cells, including breast, kidney, lung brain, etc. were reported to overexpress the folate receptor [30] . The human ovarian carcinoma SKOV3 is a widely used folate receptor positive cell line, however for human breast carcinoma MCF-7 cell line, different literature reports quite contradictory folate receptor expression levels. Jie et al. employed MCF-7 as a folate receptor overexpressed cell line [31] while Haimei et al. used MCF-7 as a negative control [32] . In this study, we tested the folate receptor expression level of the MCF-7 and SKOV3 cell lines. MCF-7 and SKOV3 cells after 4 h incubation, which was due to non-specific endocytosis [33] .
In contrast, PEG-Lip showed negligible uptake by both the MCF-7 and SKOV3 cells as a result of the PEGylation, demonstrating its excellent capabilities in decreasing the non-specific cellular uptake by not only macrophage cells but also the non-phagocytic cells, which is called the "PEG dilemma" [34] . It was reported that the addition of 5 mol % of PEG to the surface of liposomes could drastically inhibit the binding and uptake of liposomes [35] . To enhance the specific cellular uptake while at the same time decreasing the non-specific phagocytosis by immune cells, PEGylation in combination with active targeting could be an option [36, 37] . Quantitative analysis by flow cytometry (Fig. 6C ) illustrated a trend consistent with qualitative observations. Plain-Lip showed non-specific uptake by both MCF-7 and SKOV3 cells. FA-Lip and PEG-Lip had low and comparable uptake by MCF-7 cells, while the uptake of the FA-Lip by SKOV3 cells was 78% higher than that of the PEG-Lip. To demonstrate that the enhanced uptake by SKOV3 was receptor-mediated endocytosis, 1.5 mM of free folic acid was added along with the FA-Lip for the competitive uptake experiment, which was about 1000 times higher than the folate fraction of the FA-Lip. The addition of free folic acid considerably decreased the uptake of FA-Lip by SKOV3 cells, confirming ligand -receptor mediated endocytosis. It should be noted that the concentration of free folic acid was extremely high to ensure successful blocking of the cellular uptake, indicating the high specificity of the FA ligand-receptor endocytosis, possibly due to its multivalent interaction with the receptor [38, 39] . It has been reported in some studies that a molar fraction of as low as 0.03% DSPE-PEG-FA in a liposome formulation was sufficient for effective interaction with the folate receptor [40] . In this study, we found that when the total PEG density was 8%, FA density less than 4% was unable to achieve enhanced cellular uptake (data not shown). After screening, 4 mol % of DSPE-PEG-FA and 8 mol % of total PEG were selected to achieve an upregulated specific and active targeted delivery as well as downregulated unspecific phagocytosis.
Cellular uptake and penetration of liposomes in tumour spheroids
Tumour spheroids are three-dimensional (3D) tumour cell clusters [41] , which possess similar characteristics of tumour xenografts, such as extracellular matrix, cell-cell interactions [42] , spatial geometry [43] and hypoxic or necrotic regions [44] . Similar to 2D cell monolayer, Plain-Lip could be internalised into both the MCF-7 and SKOV3 tumour spheroids through non-specific binding while sterically stabilised PEG-Lips were not able to interact with any spheroids due to the effect of the PEG, which was in accordance with previously reported work using tumour spheroids [45] . FA-Lip possessed an overall enhanced accumulation in the SKOV3 spheroid, however this mainly occurred at a depth of less than 60 µm. The microenvironment in tumour spheroids plays a decisive role in tumour penetration.
With the formation of compact cell-cell interactions and high interstitial pressure in the tumour spheroids, it is not surprising to find limited penetration of the targeted liposome. Strategies such as using ultra-small nanoparticles [46] , incorporating cell penetrating peptide (CPP) [47] or tumour penetrating peptide [48] could be used to increase tumour penetration in future studies. Therefore, liposomes incorporating both the active targeting and tumour penetration enhancement will be desirable to achieve better drug delivery efficiency. Because of the simplicity and versatility of this single-step microfluidic HFF technology, it holds great potential in making various kinds of liposome formulations for actual applications. 
Conclusion
